 DANVERS, Mass.--BUSINESS WIRE--Abiomeds NASDAQ: ABMD newest right heart pump, the Impella RP with SmartAssist, has received U.S. Food and Drug Administration FDA pre-market approval PMA as safe and effective to treat acute right heart failure for up to 14 days. Impella RP with SmartAssist is the first single-access temporary percutaneous ventricular support device with dual-sensor technology. Impella RP with SmartAssist is an innovative advancement of Impella RP, which was granted a PM 